Oculus Innovative Sciences, Inc.
| Nasdaq: OCLS
Oculus Innovative Sciences, Inc. is a global healthcare company that designs, manufactures and markets prescription and non-prescription products. Its products are used to treat patients in surgical, advanced wound management, dermatology, women's health and animal health. The company's nutritional products based upon the Microcyn technology platform, which significantly reduces the need for antibiotics while reducing infections and accelerating healing. Its services include: Advanced Wound Management, Nursing Home and Home Healthcare, Dermatology, Wound and Skin Care for Consumers, Animal Healthcare and Nutraceuticals. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.